(Q77384408)
Statements
Oral and subcutaneous administration of the glycosaminoglycan C3 attenuates Abeta(25-35)-induced abnormal tau protein immunoreactivity in rat brain (English)
B Dudas
U Cornelli
J M Lee
M J Hejna
M Walzer
S A Lorens
R F Mervis
J Fareed